Menu
Back to Journals » Drug Design, Development and Therapy » Volume 12
Recent development in the strategies projected for chikungunya vaccine in humans
Authors Goyal M, Chauhan A, Goyal V, Jaiswal N, Singh S, Singh M
Received 26 July 2018
Accepted for publication 11 October 2018
Published 10 December 2018 Volume 2018:12 Pages 4195—4206
DOI https://doi.org/10.2147/DDDT.S181574
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Sukesh Voruganti
Manu Goyal,1 Anil Chauhan,2 Vishavdeep Goyal,3 Nishant Jaiswal,1,2 Shreya Singh,4 Meenu Singh1,2
1Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India; 2Indian Council of Medical Research Advanced Centre for Evidence Based Child Health, Postgraduate Institute of Medical Education and Research, Chandigarh, India; 3Apollo Hospitals International Limited, Ahmedabad, India; 4Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
Abstract: The unprecedented epidemic spread of chikungunya worldwide illustrates the critical need for potent vaccines and therapeutic interventions. The morbidity and mortality associated with this arboviral infection has become a major public health problem in many countries across different continents. Increasing public–private partnerships have opened new avenues in research and development of vaccines. This review mainly focuses on the recent advances in patented approaches for chikungunya vaccine development and the forthcoming challenges.
Keywords: chikungunya, epidemics, CHIKV vaccine candidates, clinical trials, humans
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.